Eisai, Biogen’s Alzheimer’s drug price should not dent demand – analysts
(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd
Eisai
Eisai files for full FDA approval for Alzheimer’s drug Leqembi
(Reuters) – Japanese drugmaker Eisai Co Ltd said on Saturday
Factbox-Who can get the newly approved Eisai and Biogen Alzheimer’s drug?
(Reuters) – The U.S. Food and Drug Administration on Friday
Eisai, Biogen Alzheimer’s drug could be available to some next year
By Deena Beasley and Julie Steenhuysen SAN FRANCISCO (Reuters) –
REPORT: Biogen, Eisai Began Application For Alzheimer’s Drug
Biogen, and its Japanese partner Eisai, announced Monday that it